SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
----------------
SCHEDULE 13D
(Rule 13d-101)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO
RULE 13d-2(a)
(Amendment No. 2 )(1)
American Medical Security Group, Inc.
--------------------------------------------------------------------------------
(Name of Issuer)
Common Stock No Par Value
--------------------------------------------------------------------------------
(Title of Class of Securities)
02744P101
--------------------------------------------------------------------------------
(CUSIP Number)
Scott B. Bernstein, Esq.,
Caxton Corporation,
315 Enterprise Drive Plainsboro
New Jersey 08536
(609) 936-2580
--------------------------------------------------------------------------------
(Name, Address and Telephone Number of Person Authorized to Receive Notices
and Communications)
December 28, 2000
--------------------------------------------------------------------------------
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to
report the acquisition that is the subject of this Schedule 13D, and is filing
this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the
following box |_|.
Note. Schedules filed in paper format shall include a signed
original and five copies of the schedule, including all exhibits. See Rule
13d-7(b) for other parties to whom copies are to be sent.
(Continued on following pages)
-----------------
(1) The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which would
alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section of
the Act but shall be subject to all other provisions of the Act (however, see
the Notes).
(Page 1 of 8 Pages)
<PAGE>
CUSIP No. 02744P101 SCHEDULE 13D Page 2 of 8 Pages
--------------------------------------------------------------------------------
1 NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Caxton International Limited
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) |_|
(b) |_|
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
WC
--------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEM 2(d) or 2(e) |_|
--------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
British Virgin Islands
--------------------------------------------------------------------------------
7 SOLE VOTING POWER
0
--------------------------------------------------------
NUMBER OF 8 SHARED VOTING POWER
SHARES
BENEFICIALLY 1,092,400
OWNED BY --------------------------------------------------------
EACH 9 SOLE DISPOSITIVE POWER
REPORTING
PERSON 0
WITH --------------------------------------------------------
10 SHARED DISPOSITIVE POWER
1,092,400
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,092,400
--------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES* |_|
--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
7.6%
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
CO
--------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
CUSIP No. 02744P101 SCHEDULE 13D Page 3 of 8 Pages
--------------------------------------------------------------------------------
1 NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Bruce S. Kovner
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) |_|
(b) |_|
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
Not Applicable
--------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEM 2(d) or 2(e) |_|
--------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
United States
--------------------------------------------------------------------------------
7 SOLE VOTING POWER
0
--------------------------------------------------------
NUMBER OF 8 SHARED VOTING POWER
SHARES
BENEFICIALLY 1,092,400
OWNED BY --------------------------------------------------------
EACH 9 SOLE DISPOSITIVE POWER
REPORTING
PERSON 0
WITH --------------------------------------------------------
10 SHARED DISPOSITIVE POWER
1,092,400
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,092,400
--------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES* |_|
--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
7.6%
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
IN
--------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
This Amendment 2 to Schedule 13D relates to the Common Stock, no par
value (the "Common Stock"), of American Medical Security Group, Inc., a
Wisconsin corporation (the "Company"), 3100 AMS Blvd., Green Bay, WI 54313.
Item 3: Source and Amount of Funds or Other Consideration.
Item 3 of the Schedule 13D is hereby amended by replacing the paragraph
therein with the following paragraph:
"A net aggregate of $365,999.93 (excluding commissions, if any) was
paid in a series of transactions pursuant to which Caxton International
acquired and sold the shares of Common Stock since March 15, 2000. The
purchase price for such acquired shares was paid out of Caxton
International's working capital."
Item 5: Interest in Securities of the Issuer.
The first paragraph of subparagraph (a) of Item 5 of the Schedule 13D is
hereby amended by replacing said paragraph with the following paragraph:
"(a) Caxton International beneficially owns 1,092,400 shares of
Common Stock, representing approximately 7.6% of the total shares of
Common Stock issued and outstanding. The increase in beneficial ownership
from the date of Amendment No. 1 to Schedule 13D filed March 15, 2000 is a
result of Caxton International's net acquisition of additional Common
Stock as set forth in Schedule A.
Subparagraph (c) of Item 5 of the Schedule 13D is hereby amended by adding
the following sentence:
(c) Caxton International Limited acquired additional shares and/or
sold shares of Common Stock in a series of open market transactions
effected primarily with independent brokers and, to a lesser extent,
directly with market makers utilizing the NASDAQ System, between March 15,
2000 and December 28, 2000. See Schedule A for disclosure of (1) the date,
(2) the price and (3) the amount of shares purchased and/or sold by Caxton
International Limited during the past 60 days.
<PAGE>
After reasonable inquiry and to the best of the undersigneds' knowledge
and belief, the undersigned certify that the information set forth in this
statement is true, complete and correct.
January 3, 2001 CAXTON INTERNATIONAL LIMITED
By: /s/ Joseph Kelly
--------------------------------------------
Name: Joseph Kelly
Title: Vice President & Treasurer
By: /s/ Maxwell Quin
----------------------------------------------
Name: Maxwell Quin
Title: Vice President & Secretary
/s/ Bruce S. Kovner
-------------------------------------------------
Bruce S. Kovner, by Scott B. Bernstein as
Attorney-in-Fact
<PAGE>
Schedule A
Caxton International
Limited
No of Shares Price Per Share
Trade Date Purchased (Sold) (Excluding Commission)
2-Nov 5,000 $4.47500
3-Nov 5,000 4.61250
6-Nov 6,000 3.99480
20-Nov 500 5.00000
22-Nov 1,000 4.62500
24-Nov 1,000 4.56240
29-Nov 100 5.37500
30-Nov 1,500 5.43750
5-Dec 600 5.02080
6-Dec 2,000 4.88750
14-Dec 1,000 4.25000
15-Dec 2,100 4.10710
20-Dec 2,200 4.35800
21-Dec 400 5.06250
21-Dec 2,000 5.32150
22-Dec 1,300 5.50000
22-Dec (5,000) 5.43750
27-Dec 5,000 5.33750
28-Dec 2,000 5.56250
<PAGE>
Exhibit Index
Exhibit 1 - Joint Acquisition Statement Pursuant To Rule 13d-1(k)(1).
